Your browser doesn't support javascript.
loading
Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial.
Gopaluni, Seerapani; Smith, Rona M; Lewin, Michelle; McAlear, Carol A; Mynard, Kim; Jones, Rachel B; Specks, Ulrich; Merkel, Peter A; Jayne, David R W.
Afiliación
  • Gopaluni S; University of Cambridge Hospitals NHS Foundation Trust, Cambridge, UK.
  • Smith RM; University of Cambridge Hospitals NHS Foundation Trust, Cambridge, UK. Ronasmith@doctors.net.uk.
  • Lewin M; Addenbrooke's Hospital, Box 118, Hills Road, Cambridge, CB2 0QQ, UK. Ronasmith@doctors.net.uk.
  • McAlear CA; University of Cambridge Hospitals NHS Foundation Trust, Cambridge, UK.
  • Mynard K; Division of Rheumatology and Department of Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.
  • Jones RB; University of Cambridge Hospitals NHS Foundation Trust, Cambridge, UK.
  • Specks U; University of Cambridge Hospitals NHS Foundation Trust, Cambridge, UK.
  • Merkel PA; Department of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
  • Jayne DR; Division of Rheumatology and Department of Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.
Trials ; 18(1): 112, 2017 03 07.
Article en En | MEDLINE | ID: mdl-28270229

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azatioprina / Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos / Rituximab / Inmunosupresores Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia / Europa / Oceania Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azatioprina / Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos / Rituximab / Inmunosupresores Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia / Europa / Oceania Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido